Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1924 1
1948 2
1969 1
1970 1
1972 1
1976 8
1978 4
1979 3
1980 4
1981 4
1982 3
1983 14
1984 17
1985 15
1986 15
1987 13
1988 11
1989 24
1990 19
1991 22
1992 14
1993 18
1994 26
1995 20
1996 38
1997 38
1998 24
1999 31
2000 23
2001 34
2002 26
2003 33
2004 33
2005 39
2006 52
2007 52
2008 52
2009 58
2010 71
2011 72
2012 55
2013 84
2014 87
2015 74
2016 92
2017 108
2018 136
2019 126
2020 154
2021 148
2022 168
2023 164
2024 179

Text availability

Article attribute

Article type

Publication date

Search Results

2,243 results

Results by year

Filters applied: . Clear all
Page 1
Effect of Repeated Low-Level Red-Light Therapy for Myopia Control in Children: A Multicenter Randomized Controlled Trial.
Jiang Y, Zhu Z, Tan X, Kong X, Zhong H, Zhang J, Xiong R, Yuan Y, Zeng J, Morgan IG, He M. Jiang Y, et al. Ophthalmology. 2022 May;129(5):509-519. doi: 10.1016/j.ophtha.2021.11.023. Epub 2021 Dec 1. Ophthalmology. 2022. PMID: 34863776 Free article. Clinical Trial.
PURPOSE: To assess the efficacy and safety of repeated low-level red-light (RLRL) therapy in myopia control in children. DESIGN: Multicenter, randomized, parallel-group, single-blind clinical trial. ...No severe adverse events (sudden vision loss 2 lines or s …
PURPOSE: To assess the efficacy and safety of repeated low-level red-light (RLRL) therapy in myopia control in children …
Repeated Low-level Red-light Therapy: The Next Wave in Myopia Management?
Salzano AD, Khanal S, Cheung NL, Weise KK, Jenewein EC, Horn DM, Mutti DO, Gawne TJ. Salzano AD, et al. Optom Vis Sci. 2023 Dec 1;100(12):812-822. doi: 10.1097/OPX.0000000000002083. Epub 2023 Oct 25. Optom Vis Sci. 2023. PMID: 37890098 Review.
This article provides an evidence-based review of the safety and myopia control efficacy of red light and discusses the potential mechanisms by which red light may work to slow childhood myopia progression.The spectral composition of the ambient light …
This article provides an evidence-based review of the safety and myopia control efficacy of red light and discusses the potent …
Repeated Low-Level Red-Light Therapy for Controlling Onset and Progression of Myopia-a Review.
Zhu Q, Cao X, Zhang Y, Zhou Y, Zhang J, Zhang X, Zhu Y, Xue L. Zhu Q, et al. Int J Med Sci. 2023 Sep 4;20(10):1363-1376. doi: 10.7150/ijms.85746. eCollection 2023. Int J Med Sci. 2023. PMID: 37786442 Free PMC article. Review.
Repeated low-level red-light (RLRL), characterized by increased energy supply and cellular metabolism, thus enhancing metabolic repair processes, has gained persistent worldwide attention in recent years as a new novel scientific approach for therapeutic application …
Repeated low-level red-light (RLRL), characterized by increased energy supply and cellular metabolism, thus enhancing metaboli …
Efficacy of Repeated Low-Level Red-Light Therapy for Slowing the Progression of Childhood Myopia: A Systematic Review and Meta-analysis.
Tang J, Liao Y, Yan N, Dereje SB, Wang J, Luo Y, Wang Y, Zhou W, Wang X, Wang W. Tang J, et al. Am J Ophthalmol. 2023 Aug;252:153-163. doi: 10.1016/j.ajo.2023.03.036. Epub 2023 Apr 7. Am J Ophthalmol. 2023. PMID: 37030495 Review.
PURPOSE: To evaluate the long-term efficacy and safety of repeated low-intensity red light (RLRL) treatment for childhood myopia. DESIGN: Systematic review and meta-analysis METHODS: We searched PubMed, Web of Science, CNKI, and Wanfang from inception to February 8, …
PURPOSE: To evaluate the long-term efficacy and safety of repeated low-intensity red light (RLRL) treatment for childhood myop …
Longitudinal Changes and Predictive Value of Choroidal Thickness for Myopia Control after Repeated Low-Level Red-Light Therapy.
Xiong R, Zhu Z, Jiang Y, Wang W, Zhang J, Chen Y, Bulloch G, Yuan Y, Zhang S, Xuan M, Zeng J, He M. Xiong R, et al. Ophthalmology. 2023 Mar;130(3):286-296. doi: 10.1016/j.ophtha.2022.10.002. Epub 2022 Oct 11. Ophthalmology. 2023. PMID: 36240954 Free article. Clinical Trial.
PURPOSE: To evaluate longitudinal changes in macular choroidal thickness (mCT) in myopic children treated for 1 year with repeated low-level red-light (RLRL) therapy and their predictive value for treatment efficacy on myopia control. ...PARTICIPANTS: Myopic …
PURPOSE: To evaluate longitudinal changes in macular choroidal thickness (mCT) in myopic children treated for 1 year with repeated low-level …
Myopia Control Effect of Repeated Low-Level Red-Light Therapy in Chinese Children: A Randomized, Double-Blind, Controlled Clinical Trial.
Dong J, Zhu Z, Xu H, He M. Dong J, et al. Ophthalmology. 2023 Feb;130(2):198-204. doi: 10.1016/j.ophtha.2022.08.024. Epub 2022 Aug 29. Ophthalmology. 2023. PMID: 36049646 Free article. Clinical Trial.
PURPOSE: Repeated low-level red-light (RLRL) therapy is an emerging treatment for myopia control. Nevertheless, previous studies are limited by open-label design. ...METHODS: Participants were assigned randomly in a 1:1 ratio to the RLRL group or the sham dev …
PURPOSE: Repeated low-level red-light (RLRL) therapy is an emerging treatment for myopia control. Nevertheless, previou …
Reverse skin aging signs by red light photobiomodulation.
Couturaud V, Le Fur M, Pelletier M, Granotier F. Couturaud V, et al. Skin Res Technol. 2023 Jul;29(7):e13391. doi: 10.1111/srt.13391. Skin Res Technol. 2023. PMID: 37522497 Free PMC article.
BACKGROUND: Photobiomodulation is a process by which the absorption of red light energy produces a series of physiological effects at the cellular level such as the enhancement of mitochondrial Adenosine Triphosphate (ATP) production, cell signaling and growth facto …
BACKGROUND: Photobiomodulation is a process by which the absorption of red light energy produces a series of physiological eff …
Sustained and rebound effect of repeated low-level red-light therapy on myopia control: A 2-year post-trial follow-up study.
Xiong R, Zhu Z, Jiang Y, Kong X, Zhang J, Wang W, Kiburg K, Yuan Y, Chen Y, Zhang S, Xuan M, Zeng J, Morgan IG, He M. Xiong R, et al. Clin Exp Ophthalmol. 2022 Dec;50(9):1013-1024. doi: 10.1111/ceo.14149. Epub 2022 Sep 7. Clin Exp Ophthalmol. 2022. PMID: 36054314 Free PMC article. Clinical Trial.
BACKGROUND: To evaluate the long-term efficacy and safety of continued repeated low-level red-light (RLRL) therapy on myopia control over 2 years, and the potential rebound effect after treatment cessation. ...Likewise, those who continued to merely wear SVS …
BACKGROUND: To evaluate the long-term efficacy and safety of continued repeated low-level red-light (RLRL) therapy on m …
Red Light-Triggered Anti-Angiogenic and Photodynamic Combination Therapy of Age-Related Macular Degeneration.
Xu S, Cui K, Long K, Li J, Fan N, Lam WC, Liang X, Wang W. Xu S, et al. Adv Sci (Weinh). 2023 Nov;10(31):e2301985. doi: 10.1002/advs.202301985. Epub 2023 Sep 14. Adv Sci (Weinh). 2023. PMID: 37705491 Free PMC article.
Combined therapy with photodynamic therapy (PDT) and anti-angiogenic agents has emerged as a novel treatment paradigm. ...The study enables an efficient intravenous wAMD therapy by integrating a photoactivation process with combinational therapeutics i …
Combined therapy with photodynamic therapy (PDT) and anti-angiogenic agents has emerged as a novel treatment paradigm. ...The …
Red light therapy for myopia: Merits, risks and questions.
Schaeffel F, Wildsoet CF. Schaeffel F, et al. Ophthalmic Physiol Opt. 2024 Jul;44(5):801-807. doi: 10.1111/opo.13306. Epub 2024 Apr 2. Ophthalmic Physiol Opt. 2024. PMID: 38563650 No abstract available.
2,243 results